Evidence map›Paper›PMID 27886248›Full record

ArticleScientific reports2016

Ultrasensitive, rapid and inexpensive detection of DNA using paper based lateral flow assay.

Miriam Jauset-Rubio, Markéta Svobodová, Teresa Mairal, Calum McNeil, Neil Keegan, Ayman Saeed, Mohammad Nooredeen Abbas, Mohammad S El-Shahawi, Abdulaziz S Bashammakh, Abdulrahman O Alyoubi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 173 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. A rapid test for protein-DNA interactions.Nucleic acids research · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Miriam Jauset-RubioNanobiotechnology and Bioanalysis group, Department of Chemical Engineering, Universitat Rovira I Virgili, 43007 Tarragona, Spain.
Markéta SvobodováNanobiotechnology and Bioanalysis group, Department of Chemical Engineering, Universitat Rovira I Virgili, 43007 Tarragona, Spain.
Teresa MairalNanobiotechnology and Bioanalysis group, Department of Chemical Engineering, Universitat Rovira I Virgili, 43007 Tarragona, Spain.
Calum McNeilInstitute of Cellular Medicine, Diagnostic and Therapeutic Technologies Group, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
Neil KeeganInstitute of Cellular Medicine, Diagnostic and Therapeutic Technologies Group, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
Ayman SaeedNational Research Centre, Cairo, Egypt.
Mohammad Nooredeen AbbasNational Research Centre, Cairo, Egypt.
Mohammad S El-ShahawiDepartment of Chemistry, Faculty of Science, King Abdulaziz University, P. O. Box 80203, Jeddah 21589, Kingdom of Saudi Arabia.
Abdulaziz S BashammakhDepartment of Chemistry, Faculty of Science, King Abdulaziz University, P. O. Box 80203, Jeddah 21589, Kingdom of Saudi Arabia.
Abdulrahman O AlyoubiDepartment of Chemistry, Faculty of Science, King Abdulaziz University, P. O. Box 80203, Jeddah 21589, Kingdom of Saudi Arabia.
Ciara K O SullivanNanobiotechnology and Bioanalysis group, Department of Chemical Engineering, Universitat Rovira I Virgili, 43007 Tarragona, Spain.
King Abdulaziz University · SAUniversidad Rovira i Virgili · ESNational Research Centre · EGNewcastle University · GBInstitució Catalana de Recerca i Estudis Avançats · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sensitive, specific, rapid, inexpensive and easy-to-use nucleic acid tests for use at the point-of-need are critical for the emerging field of personalised medicine for which companion diagnostics are essential, as well as for application in low resource settings. Here we report on the development of a point-of-care nucleic acid lateral flow test for the direct detection of isothermally amplified DNA. The recombinase polymerase amplification method is modified slightly to use tailed primers, resulting in an amplicon with a duplex flanked by two single stranded DNA tails. This tailed amplicon facilitates detection via hybridisation to a surface immobilised oligonucleotide capture probe and a gold nanoparticle labelled reporter probe. A detection limit of 1 × 10

Indexed as

PaperDNAGoldLimit of DetectionMetal NanoparticlesPoint-of-Care SystemsPolymerase Chain ReactionDNAGold

Identifiers

PMID27886248
PMCPMC5123575
OpenAlexW2555713419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.